Thyssen Jacob P, Heegaard Steffen, Ivert Lena, Remitz Anita, Agner Tove, De Bruin-Weller Marjolein, Huldt-Nystrøm Theis, Korhonen Laura, Ivert Lina U, Leinonen Pekka, Mandelin Johanna, Särnhult Tore, Schopf Thomas, Sundlisæter Eirik, Thomsen Simon F, Tzellos Thrasyvoulos, Vestergaard Christian, von Kobyletzki Laura, Bradley Maria
Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, DK-2900 Hellerup, Denmark. E-mail:
Acta Derm Venereol. 2020 Sep 16;100(16):adv00264. doi: 10.2340/00015555-3629.
There is a need for unified guidance on the management of ocular manifestations of atopic dermatitis and ocular manifestations associated with dupilumab in the Nordic region (Denmark, Finland, Norway and Sweden). This initiative gathered Nordic dermatologists and ophthalmologists to identify consensus in this area using a modified Delphi process. The initiative was led by a Nordic expert panel who developed a questionnaire that was circulated to a wider group. The results informed an agenda consisting of 24 statements to be voted on using a 5-point Likert scale at a meeting in Copenhagen on 24 April 2019. A facilitator moderated discussion and revised statements according to expert feedback for a second vote when required to reach consensus. Consensus was reached for 23 statements regarding the diagnosis, treatment and referral of these patients, which we hope will improve patient management in the Nordic region.
在北欧地区(丹麦、芬兰、挪威和瑞典),对于特应性皮炎眼部表现以及与度普利尤单抗相关的眼部表现的管理,需要统一的指导意见。该倡议召集了北欧的皮肤科医生和眼科医生,通过改良的德尔菲法在这一领域达成共识。该倡议由一个北欧专家小组牵头,他们制定了一份调查问卷,并分发给更广泛的群体。结果形成了一份包含24项声明的议程,于2019年4月24日在哥本哈根的一次会议上采用5级李克特量表进行投票。一名主持人主持讨论,并根据专家反馈修订声明,必要时进行第二轮投票以达成共识。就这些患者的诊断、治疗和转诊的23项声明达成了共识,我们希望这将改善北欧地区的患者管理。